Keystone Resort Floorplan
Registered Attendees
Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting
(You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
- Full participant list, including joint meeting participants
- Printable Invoices and Invitation Letters
- Scholarship Information
- Lodging Information
Login to My Account page
This meeting took place in 2012
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
HIV Vaccines (X5)
Organizer(s) Gunilla B. Karlsson Hedestam, Andrew McMichael and Christopher J. Miller
March 21—26, 2012
Keystone Resort • Keystone, Colorado USA
Abstract Deadline: Nov 21, 2011
Late Abstract Deadline: Dec 22, 2011
Scholarship Deadline: Nov 21, 2011
Early Registration Deadline: Jan 20, 2012
Part of the Keystone Symposia Global Health Series, Supported by the Bill & Melinda Gates Foundation. Sponsored by Sangamo BioSciences, Inc.
Joint Meeting:
Viral Immunity and Host Gene Influence (X6)
Summary of Meeting:
The 2012 Keystone Symposia meeting on HIV Vaccines will focus on basic aspects of immunology and HIV-1 virology to highlight issues that challenge the field. The genetic diversity of circulating HIV-1 variants puts extreme demands on the quality of the response a prophylactic vaccine will need to elicit. Most likely, conserved viral determinants need to be targeted and the response must be sustained over time. To facilitate a broad and open discussion around these topics, the symposium will convene expert investigators from the HIV-1 vaccine field as well as a number of basic immunologists. Aspects of natural HIV-1 infection of direct relevance to the development of a vaccine, such as viral transmission and viral escape from immune responses, will be addressed in joint sessions with the parallel meeting on Viral Immunity and Host Gene Influence. Speakers will also be invited to present in the workshops and in the oral sessions based on submitted abstracts.
View Scholarships/Awards
The 2012 Keystone Symposia meeting on HIV Vaccines will focus on basic aspects of immunology and HIV-1 virology to highlight issues that challenge the field. The genetic diversity of circulating HIV-1 variants puts extreme demands on the quality of the response a prophylactic vaccine will need to elicit. Most likely, conserved viral determinants need to be targeted and the response must be sustained over time. To facilitate a broad and open discussion around these topics, the symposium will convene expert investigators from the HIV-1 vaccine field as well as a number of basic immunologists. Aspects of natural HIV-1 infection of direct relevance to the development of a vaccine, such as viral transmission and viral escape from immune responses, will be addressed in joint sessions with the parallel meeting on Viral Immunity and Host Gene Influence. Speakers will also be invited to present in the workshops and in the oral sessions based on submitted abstracts.
View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference
WEDNESDAY, MARCH 21
THURSDAY, MARCH 22
FRIDAY, MARCH 23
SATURDAY, MARCH 24
SUNDAY, MARCH 25
MONDAY, MARCH 26
Conference Program Print | View meeting in 12 hr (am/pm) time
WEDNESDAY, MARCH 21
19:15—19:30
Welcome Address by the Organizers (Joint)
19:30—21:30
Keynote Session (Joint)
Meeting has ended...abstracts no longer viewable online.
*
Naglaa Shoukry,
University of Montreal Hospital Research Center, Canada
Stanley M. Lemon,
University of North Carolina at Chapel Hill, USA
Divergent Infection Outcomes Marked by Similarities and Differences in Induction and Evasion of Interferon Responses by Hepatotropic RNA Viruses
Divergent Infection Outcomes Marked by Similarities and Differences in Induction and Evasion of Interferon Responses by Hepatotropic RNA Viruses
Joseph G. Sodroski,
Dana-Farber Cancer Institute, USA
Structure of the Membrane-Anchored HIV-1 Envelope Glycoprotein Trimer Complex by Cryoelectron Microscopy
Structure of the Membrane-Anchored HIV-1 Envelope Glycoprotein Trimer Complex by Cryoelectron Microscopy
08:00—11:00
HIV-1/SIV Transmission
Meeting has ended...abstracts no longer viewable online.
*
Daniel C. Douek,
NIAID, National Institutes of Health, USA
Beatrice H. Hahn,
University of Pennsylvania, USA
Biology of Transmitted/Founder Viruses
Biology of Transmitted/Founder Viruses
Damien Tully,
Ragon Institute of MGH, MIT and Harvard, USA
A Deeper View of Transmitted/Founder Viruses during Acute HIV-1 Infection using 454 Whole Genome Deep Sequencing
A Deeper View of Transmitted/Founder Viruses during Acute HIV-1 Infection using 454 Whole Genome Deep Sequencing
Thomas J. Hope,
Northwestern University, USA
Defining the Mechanisms of Heterosexual HIV Transmission
Defining the Mechanisms of Heterosexual HIV Transmission
Christopher J. Miller,
University of California, Davis, USA
Lessons Learned from Recapitulating the Step Trial in NHP
Lessons Learned from Recapitulating the Step Trial in NHP
Kamini Gounder,
Doris Duke Medical Research Institute, University of KwaZulu Natal, South Africa
Short Talk: Viral Evolution and Immune Escape in Gag during Acute HIV-1 Subtype C Infection
Short Talk: Viral Evolution and Immune Escape in Gag during Acute HIV-1 Subtype C Infection
08:00—11:15
Innate Immune Responses to Virus Infection
Meeting has ended...abstracts no longer viewable online.
Jae U. Jung,
Keck School of Medicine of University of Southern California, USA
IFITM-Mediated Intracellular Anti-Viral Restriction
IFITM-Mediated Intracellular Anti-Viral Restriction
*
Mariapia A. Degli-Esposti,
LEI, University of Western Australia, Australia
NK Cell Immune Mechanisms in a Natural Host-Pathogen System
NK Cell Immune Mechanisms in a Natural Host-Pathogen System
Andrew G. Brooks,
University of Melbourne, Australia
Killer Immunoglobulin Receptor 3DL1-Mediated Recognition of HLA-A and –B Allotypes
Killer Immunoglobulin Receptor 3DL1-Mediated Recognition of HLA-A and –B Allotypes
Michael A. Schmid,
Humabs – Vir Biotechnology, Switzerland
Short Talk: Dendritic Cells and the Immune Response to Dengue Virus Infection in the Skin
Short Talk: Dendritic Cells and the Immune Response to Dengue Virus Infection in the Skin
Béhazine Combadière,
INSERM, France
Short Talk: Neutrophils Drag and Drop Antigen from the Dermis to the Bone Marrow Initiating an Alternative Source of Long-Lived Memory CD8+ T Cells
Short Talk: Neutrophils Drag and Drop Antigen from the Dermis to the Bone Marrow Initiating an Alternative Source of Long-Lived Memory CD8+ T Cells
11:00—12:30
Hands On Computer Workshop on Los Alamos SEQUENCE DATABASE and Tools
Maximum attendance: 60. Interested participants must sign up at the meeting on a first-come, first-serve basis.
Instructors: Brian Foley, Bette Korber and Carla Kuiken.
Instructors: Brian Foley, Bette Korber and Carla Kuiken.
14:30—16:30
Workshop 1: HIV-1/SIV Transmission and NHP Protection Studies
*
Eric Hunter,
Emory University, USA
*
Christopher J. Miller,
University of California, Davis, USA
Debby Basu,
Emory University, USA
Intra-Subtype C HIV-1 Superinfection Occurs Prior to Robust Neutralizing Antibody Responses in the Newly Infected Partner
Intra-Subtype C HIV-1 Superinfection Occurs Prior to Robust Neutralizing Antibody Responses in the Newly Infected Partner
Katja Pfafferott,
Weatherall Institute of Molecular Medicine, UK
Analysis of Two Clade A Transmission Pairs with Contrasting Clinical Outcomes Suggests Contributions of the Founder Virus and Host CD8 T Cell Response to Set-Point Viremia
Analysis of Two Clade A Transmission Pairs with Contrasting Clinical Outcomes Suggests Contributions of the Founder Virus and Host CD8 T Cell Response to Set-Point Viremia
Rama Rao Amara,
Emory University, USA
GM-CSF Expressed by DNA but Not MVA Enhances Prevention of Acquisition by a Heterologous Mucosal Challenge
GM-CSF Expressed by DNA but Not MVA Enhances Prevention of Acquisition by a Heterologous Mucosal Challenge
Shari N. Gordon,
NCI, National Institutes of Health, USA
Human Papillomavirus Pseudovirion Vaccines Delivering SIV DNA Partially Protects from Mucosal SIVmac251 Infection
Human Papillomavirus Pseudovirion Vaccines Delivering SIV DNA Partially Protects from Mucosal SIVmac251 Infection
Brian Moldt,
The Scripps Research Institute, USA
Non-Fucosylated b12 has Enhanced FcyRIIIa-Mediated Antiviral Activity in vitro but Not Improved Protection against Mucosal SHIV Challenge in Macaques
Non-Fucosylated b12 has Enhanced FcyRIIIa-Mediated Antiviral Activity in vitro but Not Improved Protection against Mucosal SHIV Challenge in Macaques
Amarendra Pegu,
NIAID, National Institutes of Health, USA
VRC01 Provides Sterilizing Protection to Non Human Primates from Mucosal SHIV Challenges
VRC01 Provides Sterilizing Protection to Non Human Primates from Mucosal SHIV Challenges
Adrienne E. Swanstrom,
University of Pennsylvania, USA
In vitro and in vivo Characterization of a Novel Variant of SIVmac239 Lacking CD4 Tropism
In vitro and in vivo Characterization of a Novel Variant of SIVmac239 Lacking CD4 Tropism
Liang Shang,
University of Minnesota, USA
Natural Killer Cells Are Critical to Control Viral Infection in the Female Genital Tract of Rhesus Macaque after SIV Vaginal Challenge
Natural Killer Cells Are Critical to Control Viral Infection in the Female Genital Tract of Rhesus Macaque after SIV Vaginal Challenge
17:00—19:00
B Cells and Neutralizing Antibodies
Meeting has ended...abstracts no longer viewable online.
*
Michel C. Nussenzweig,
HHMI/Rockefeller University, USA
David M. Tarlinton,
Monash University, Australia
Memory B Cell and Plasma Cell Development in Response to Vaccination
Memory B Cell and Plasma Cell Development in Response to Vaccination
Dennis R. Burton,
The Scripps Research Institute, USA
Neutralizing Antibody Targets on the HIV-1 Spike
Neutralizing Antibody Targets on the HIV-1 Spike
Gary J. Nabel,
Sanofi, USA
Generation of Broadly Neutralizing Antibodies in an AIDS Vaccine: The End of the Beginning
Generation of Broadly Neutralizing Antibodies in an AIDS Vaccine: The End of the Beginning
Jinghe Huang,
NIAID, National Institutes of Health, USA
Short Talk: Isolation of a Broad, Potent, MPER-Specific Monoclonal Antibody with Novel Binding Characteristics
Short Talk: Isolation of a Broad, Potent, MPER-Specific Monoclonal Antibody with Novel Binding Characteristics
17:00—19:00
Systems Approaches to Virus-Host Interactions
Meeting has ended...abstracts no longer viewable online.
Alan Aderem,
Center for Infectious Disease Research, USA
A Systems Approach to Dissecting Immunity
A Systems Approach to Dissecting Immunity
*
Ralph S. Baric,
University of North Carolina at Chapel Hill, USA
Systems Genetics and Respiratory Virus Pathogenomics
Systems Genetics and Respiratory Virus Pathogenomics
Alison Simmons,
Weatherall Institute of Molecular Medicine, UK
Early Host Responses to HIV Infection
Early Host Responses to HIV Infection
Nathan P. Croft,
University of Melbourne, Australia
Short Talk: Quantitative Kinetics of Antigen Presentation during Viral Infection
Short Talk: Quantitative Kinetics of Antigen Presentation during Viral Infection
08:00—11:15
Stimulation of Adaptive Immune Responses (Joint)
Meeting has ended...abstracts no longer viewable online.
*
Kevin L. Legge,
University of Iowa Carver College of Medicine, USA
Laurence C. Eisenlohr,
Children's Hospital of Philadelphia and University of Pennsylvania, USA
MHC Class II-Restricted Processing Pathways for Viral Antigens
MHC Class II-Restricted Processing Pathways for Viral Antigens
Chris C. Norbury,
Pennsylvania State University Medical School, USA
Short Talk: Assessing the Role of APC Phenotype and Maturation Status upon the Contribution of Direct and Cross Antigen Presentation during a Natural Virus Infection
Short Talk: Assessing the Role of APC Phenotype and Maturation Status upon the Contribution of Direct and Cross Antigen Presentation during a Natural Virus Infection
Gunilla B. Karlsson Hedestam,
Karolinska Institutet, Sweden
Properties of B Cell Responses Elicited By Soluble HIV-1 Env Trimers
Properties of B Cell Responses Elicited By Soluble HIV-1 Env Trimers
Laura E. McCoy,
University College London, UK
Short Talk: Potent Multi-Clade Neutralization of HIV-1 by a Llama VHH Antibody Induced by Immunization
Short Talk: Potent Multi-Clade Neutralization of HIV-1 by a Llama VHH Antibody Induced by Immunization
Marc K. Jenkins,
University of Minnesota Medical School, USA
Maintenance of Protective CD4+ “Memory” T Cells during Persistent Phagosomal Infection
Maintenance of Protective CD4+ “Memory” T Cells during Persistent Phagosomal Infection
David Price,
Cardiff University School of Medicine, UK
The Clonotypic Basis of Adaptive T Cell Immunity
The Clonotypic Basis of Adaptive T Cell Immunity
11:15—12:45
Hands On Computer Workshop on Los Alamos IMMUNOLOGY DATABASE and Tools
Maximum attendance: 60. Interested participants must sign up at the meeting on a first-come, first-serve basis.
Instructors: Brian Foley, Bette Korber and Carla Kuiken.
Instructors: Brian Foley, Bette Korber and Carla Kuiken.
14:30—16:30
Workshop 2: B Cells and Neutralizing Antibodies
*
Nicole A. Doria-Rose,
NIAID, National Institutes of Health, USA
*
James A. Hoxie,
University of Pennsylvania, USA
Torben Schiffner,
The Scripps Research Institute, USA
Modulating Immunogenicity by Chemical Modification of gp140
Modulating Immunogenicity by Chemical Modification of gp140
Mattias Forsell,
Umeå University, Sweden
Targeted Immunosilencing Reveals Independent Regulation of Epitope Specific B Cell Responses to HIV-1 Env
Targeted Immunosilencing Reveals Independent Regulation of Epitope Specific B Cell Responses to HIV-1 Env
Elise Landais,
International AIDS Vaccine Initiative, USA
Development of Broadly Neutralizing Antibody Responses in a Large Sub-Saharan HIV Primary Infection Cohorts
Development of Broadly Neutralizing Antibody Responses in a Large Sub-Saharan HIV Primary Infection Cohorts
Jason S. McLellan,
University of Texas at Austin, USA
Structural and Biophysical Studies of Antibodies Isolated from RV144 Vaccinees
Structural and Biophysical Studies of Antibodies Isolated from RV144 Vaccinees
Lawrence S. Shapiro,
Columbia University, USA
Deep Sequencing with Longitudinal Sampling of a VRC01-Like-Antibody Response in a Chronically Infected Individual
Deep Sequencing with Longitudinal Sampling of a VRC01-Like-Antibody Response in a Chronically Infected Individual
Jordan R. Willis,
Vanderbilt University, USA
Structure Analysis of Healthy Donor Repertoire Confers Sequences that Match Long Complementary Determining Regions of Broadly Neutralizing Antibodies
Structure Analysis of Healthy Donor Repertoire Confers Sequences that Match Long Complementary Determining Regions of Broadly Neutralizing Antibodies
Samantha J. Hoot,
Seattle Biomedical Research Institute, USA
Interaction of Germline Precursors to Broadly Neutralizing Anti-CD4 Binding Site Antibodies with HIV-1 Envelope Glycoproteins
Interaction of Germline Precursors to Broadly Neutralizing Anti-CD4 Binding Site Antibodies with HIV-1 Envelope Glycoproteins
M. Gordon Joyce,
U.S. Military HIV Research Program, USA
Structures of Reverted Germline VRC01-Like Antibodies Guide HIV-1 Immunogen Design
Structures of Reverted Germline VRC01-Like Antibodies Guide HIV-1 Immunogen Design
14:30—16:30
Workshop 1
Sophie Hambleton,
Newcastle University, UK
A Defect in Type I Interferon Signaling Causes Severe Susceptibility to Some, but Not All, Viral Infections in Humans
A Defect in Type I Interferon Signaling Causes Severe Susceptibility to Some, but Not All, Viral Infections in Humans
Tao Peng,
University of Washington, USA
System Biology Approaches to Dissect Immune-Surveillance Roles of CD8+ Cells at Mucosal Surface during HSV-2 Reactivation
System Biology Approaches to Dissect Immune-Surveillance Roles of CD8+ Cells at Mucosal Surface during HSV-2 Reactivation
Daniela Weiskopf,
La Jolla Institute for Allergy and Immunology, USA
Proteome Wide Mapping of Dengue Virus-Specific T Cell Responses in Human Donors Reveals Antigenic Hot Spots and a Dominance of HLA B Restricted Responses
Proteome Wide Mapping of Dengue Virus-Specific T Cell Responses in Human Donors Reveals Antigenic Hot Spots and a Dominance of HLA B Restricted Responses
*
Michelle L. Baker,
CSIRO Livestock Industries, Australia
Immunology of an Important Viral Reservoir, the Australian Black Flying Fox
Immunology of an Important Viral Reservoir, the Australian Black Flying Fox
*
Andrew J. Yates,
University of Glasgow, UK
The Race for the Prize – Surveillance Strategies for the Efficient Induction of T Cell Responses
The Race for the Prize – Surveillance Strategies for the Efficient Induction of T Cell Responses
Allison M. W. Malloy,
Uniformed Services University of the Health Sciences, USA
CD8+ T Cell Epitope Hierarchy is Established during the Neonatal Period in Respiratory Syncytial Virus-Infected Mice
CD8+ T Cell Epitope Hierarchy is Established during the Neonatal Period in Respiratory Syncytial Virus-Infected Mice
Christopher Lupfer,
St. Jude Children's Research Hospital, USA
T Cell Intrinsic Role of Nod2 in Cellular Immunity to Virus Infection
T Cell Intrinsic Role of Nod2 in Cellular Immunity to Virus Infection
Shiki Takamura,
Kinki University Faculty of Medicine, Japan
CD69 Controls a Balance between S1P- and CXCL16-Induced Chemotaxes during the Process of Memory CD8+ T Cell Recruitment to the Lung Airways
CD69 Controls a Balance between S1P- and CXCL16-Induced Chemotaxes during the Process of Memory CD8+ T Cell Recruitment to the Lung Airways
17:00—19:00
Cellular Immunity against HIV/SIV - Messages for Vaccines
Meeting has ended...abstracts no longer viewable online.
*
Nilu Goonetilleke,
University of North Carolina at Chapel Hill, USA
*
Guido Ferrari,
Duke University Medical Center, USA
Marcus Altfeld,
Heinrich-Pette-Institute, Germany
NK Cell Mediated Immune Pressure in HIV-1 Infection
NK Cell Mediated Immune Pressure in HIV-1 Infection
Alessandra Noto,
Lausanne University Hospital, Switzerland
Short Talk: Loss of Id2 during Chronic HIV Infection is Mediated by PD-1 Triggering and is Responsible for HIV-Specific CD8+ T Cell Exhaustion
Short Talk: Loss of Id2 during Chronic HIV Infection is Mediated by PD-1 Triggering and is Responsible for HIV-Specific CD8+ T Cell Exhaustion
17:00—19:00
Adaptive Immunity: Regulating T Cell Function at the Levels of Epigenetics and TCR Activation
Meeting has ended...abstracts no longer viewable online.
Pedro R. Lowenstein,
University of Michigan School of Medicine, USA
CD8 TcR Synapses in vitro and in vivo
CD8 TcR Synapses in vitro and in vivo
Heather D. Hickman,
NIAID, National Institutes of Health, USA
Intravital Imaging of CD8+ T Cell Activation after Viral Infection
Intravital Imaging of CD8+ T Cell Activation after Viral Infection
*
Stephen J. Turner,
Monash University, Australia
Epigenetic Regulation of Virus-Specific CD8+ T Cell Responses
Epigenetic Regulation of Virus-Specific CD8+ T Cell Responses
J. Scott Hale,
University of Utah, USA
Short Talk: Distinct Memory CD4 T Cells with Commitment to the T Follicular Helper and Th1 Lineages
Short Talk: Distinct Memory CD4 T Cells with Commitment to the T Follicular Helper and Th1 Lineages
08:00—11:15
Immune Evasion and Subversion (Joint)
Meeting has ended...abstracts no longer viewable online.
Ted C. Pierson,
NIAID, National Institutes of Health, USA
A Dynamic Landscape for Antibody-Mediated Neutralization and Enhancement of Flavivirus Infection
A Dynamic Landscape for Antibody-Mediated Neutralization and Enhancement of Flavivirus Infection
*
Klaus Früh,
Oregon Health & Science University, USA
Evasion of T Cell Responses by Cytomegalovirus
Evasion of T Cell Responses by Cytomegalovirus
Hanneke Schuitemaker,
Janssen Vaccines & Prevention B.V., Netherlands
HIV-1 Dynamics in Relation to Cross-Reactive Neutralizing Humoral Immunity
HIV-1 Dynamics in Relation to Cross-Reactive Neutralizing Humoral Immunity
Nilu Goonetilleke,
University of North Carolina at Chapel Hill, USA
Short Talk: T Cell Immunodominance, Breadth and Epitope Entropy are the Major Determinants of Virus Escape in Acute HIV-1 Infection
Short Talk: T Cell Immunodominance, Breadth and Epitope Entropy are the Major Determinants of Virus Escape in Acute HIV-1 Infection
Timothy E. Dudek,
Ragon Institute of MGH, MIT and Harvard, USA
Short Talk: Accurate Recapitulation of Human Acute-Phase HIV-Specific CD8+ T-Cell Responses and Viral Evolution in Humanized BLT Mice
Short Talk: Accurate Recapitulation of Human Acute-Phase HIV-Specific CD8+ T-Cell Responses and Viral Evolution in Humanized BLT Mice
Kia Katchar,
Ragon Institute of MGH, MIT and Harvard, USA
Short Talk: Adaptation of Hepatitis C Virus (HCV) to KIR-Associated Immune Pressures
Short Talk: Adaptation of Hepatitis C Virus (HCV) to KIR-Associated Immune Pressures
11:15—11:45
The Grant Submission Process at NIH/NIAID (Joint)
The presentation will introduce the NIH/NIAID grant submission process and describe some grants available to new investigators.
Cheryl Lapham,
NIAID, National Institutes of Health, USA
14:30—16:30
Workshop 3: Cellular Immunity against SIV/HIV
*
Richard A. Koup,
NIAID, National Institutes of Health, USA
*
Bette Tina Marie Korber,
Los Alamos National Laboratory, USA
A Comparison of Conserved Region versus Full-Length Protein T Cell Vaccines in Rhesus Monkeys Reveals No Evidence for Immunofocusing
A Comparison of Conserved Region versus Full-Length Protein T Cell Vaccines in Rhesus Monkeys Reveals No Evidence for Immunofocusing
Karthik Shekhar,
Massachusetts Institute of Technology, USA
Collective Evolution in HIV Proteins Reveals Strategies for Rational HIV Vaccine Design
Collective Evolution in HIV Proteins Reveals Strategies for Rational HIV Vaccine Design
Tomas Hanke,
University of Oxford, UK
Immunogenicity of a Universal HIV-1 Vaccine Vectored by DNA, MVA and ChAdV-63 in a Phase I/IIa Clinical Trial
Immunogenicity of a Universal HIV-1 Vaccine Vectored by DNA, MVA and ChAdV-63 in a Phase I/IIa Clinical Trial
Daniel Claiborne,
Ragon Institute of MGH, MIT, and Harvard, USA
Rare HLA-Associated Gag Polymorphisms Dramatically Reduce Replicative Capacity of Transmitted Founder Viruses and Modulate Set Point Viral Load
Rare HLA-Associated Gag Polymorphisms Dramatically Reduce Replicative Capacity of Transmitted Founder Viruses and Modulate Set Point Viral Load
Sylvie Le Gall,
Massachusetts General Hospital, Harvard Medical School, USA
Sequence Signatures Define HIV Antigen Processing Mutations Leading to Immune Escape at the Population Level
Sequence Signatures Define HIV Antigen Processing Mutations Leading to Immune Escape at the Population Level
Lydie Trautmann,
US Military HIV Research Program, USA
Dissecting Function, Memory Generation, and TCR Repertoire of Effector CD8 T cells in Primary HIV Infection and other Acute Viral Infections
Dissecting Function, Memory Generation, and TCR Repertoire of Effector CD8 T cells in Primary HIV Infection and other Acute Viral Infections
Srinika R. F. Ranasinghe,
Ragon Institute of MGH, MIT and Harvard, USA
Promiscuity in Peptide-HLA Class II Interactions Impact HIV Immune Control
Promiscuity in Peptide-HLA Class II Interactions Impact HIV Immune Control
LaTonya D. Williams,
Duke University Medical Center, USA
CD4-Like Immunologic Function by IL-21-Producing CD8 T Cells in HIV-Infected Individuals
CD4-Like Immunologic Function by IL-21-Producing CD8 T Cells in HIV-Infected Individuals
14:30—16:30
Workshop 2
Christopher Brooke,
NIAID, National Institutes of Health, USA
Nine Out of Ten Influenza A Virions Can Be Wrong: The Cost of Segmentation
Nine Out of Ten Influenza A Virions Can Be Wrong: The Cost of Segmentation
Michael E. Wortzman,
University of Toronto, Canada
Role of CD8 T Cell Intrinsic TNF in Enhancing the Contraction of Short-Lived Effector Cells during Respiratory Influenza Virus Infection
Role of CD8 T Cell Intrinsic TNF in Enhancing the Contraction of Short-Lived Effector Cells during Respiratory Influenza Virus Infection
Matthieu Daugan,
INRS-Institut Armand-Frappier, Canada
Mechanisms Implicated in the Late Appearance of Neutralizing Antibodies against Lymphocytic Choriomeningitis Virus
Mechanisms Implicated in the Late Appearance of Neutralizing Antibodies against Lymphocytic Choriomeningitis Virus
*
Mario L. Santiago,
University of Colorado Denver, USA
A Single Nucleotide Polymorphism in Tetherin Promotes Retrovirus Restriction in vivo
A Single Nucleotide Polymorphism in Tetherin Promotes Retrovirus Restriction in vivo
Deepak Mittal,
University of Queensland Diamantina Institute, Australia
Mechanisms of Local Immune Suppression in HPV E7 Expressing Skin
Mechanisms of Local Immune Suppression in HPV E7 Expressing Skin
*
Pinghui Feng,
University of Southern California, USA
A Herpesvirus Selectively Hijacks an Innate Immune Signal Pathway to Enable Viral Transcriptional Activation and Disable Host Antiviral Cytokine Production
A Herpesvirus Selectively Hijacks an Innate Immune Signal Pathway to Enable Viral Transcriptional Activation and Disable Host Antiviral Cytokine Production
Amy Haseley,
Ohio State University, USA
Secreted ECM Protein CCN1 Limits Oncolytic HSV-1 Efficacy for Glioma
Secreted ECM Protein CCN1 Limits Oncolytic HSV-1 Efficacy for Glioma
Patrick C. Rämer,
University of Zürich, Switzerland
Identification of Viral Tumor-Suppressor Using a Humanized Mouse Model of EBV Infection
Identification of Viral Tumor-Suppressor Using a Humanized Mouse Model of EBV Infection
17:00—19:00
Update from Clinical Trials of HIV-1 Vaccines
Meeting has ended...abstracts no longer viewable online.
*
Lawrence Corey,
Fred Hutchinson Cancer Research Center, USA
*
Amapola Manrique,
Global HIV Vaccine Enterprise, USA
Nicole Frahm,
Bill & Melinda Gates Medical Research Institute, USA
The HIV Vaccine Landscape after Step and RV144
The HIV Vaccine Landscape after Step and RV144
Nelson L. Michael,
Walter Reed Army Institute of Research, USA
Thai Phase III Update. RV144 Follow-up: Antigenicity, Correlates, and Sieve Analysis
Thai Phase III Update. RV144 Follow-up: Antigenicity, Correlates, and Sieve Analysis
Susan Zolla-Pazner,
Icahn School of Medicine at Mount Sinai, USA
Antibodies, Variable Regions, and the RV144 Vaccine Trial Results
Antibodies, Variable Regions, and the RV144 Vaccine Trial Results
Amy W. Chung,
Ragon Institute of MGH, MIT & Harvard, USA
Short Talk: RV144 Vaccine Induces a Differential Antibody Effector Function Profile in Comparison to VAX003
Short Talk: RV144 Vaccine Induces a Differential Antibody Effector Function Profile in Comparison to VAX003
17:00—19:00
Immunity to Chronic and Persistent Viral Infections
Meeting has ended...abstracts no longer viewable online.
Mehrdad Matloubian,
University of California, San Francisco, USA
Role of Innate Sensing Pathways in Chronic Viral Infections
Role of Innate Sensing Pathways in Chronic Viral Infections
Barbara Rehermann,
NIDDK, National Institutes of Health, USA
Natural Killer Cell Function in Hepatitis C Virus Infection
Natural Killer Cell Function in Hepatitis C Virus Infection
Christopher M. Snyder,
Thomas Jefferson University, USA
Short Talk: Small Populations of Memory-Like CD8+ T Cells Undergo Memory Inflation during MCMV Infection
Short Talk: Small Populations of Memory-Like CD8+ T Cells Undergo Memory Inflation during MCMV Infection
*
Andrea Lynn Cox,
Johns Hopkins University, USA
The Missing Link between Inflammasome Complex Activation and Adaptive Immune Responses in the Transition from Acute to Chronic HCV Infection
The Missing Link between Inflammasome Complex Activation and Adaptive Immune Responses in the Transition from Acute to Chronic HCV Infection
08:00—11:00
Effective Immune Responses in Animal Models
Meeting has ended...abstracts no longer viewable online.
*
James E. Robinson,
Tulane University Health Sciences Center, USA
*
Nancy R. Miller,
NIAID, National Institutes of Health, USA
Jason M. Brenchley,
NIAID, National Institutes of Health, USA
Microbial Translocation, Immune Activation, and Disease Progression
Microbial Translocation, Immune Activation, and Disease Progression
Poonam Pegu,
NCI, National Institutes of Health, USA
Short Talk: Mucosal Transmission of a Limited Number of SIVmac251 Variants in Macaques Recapitulates HIV Vaccine Efficacy in Humans
Short Talk: Mucosal Transmission of a Limited Number of SIVmac251 Variants in Macaques Recapitulates HIV Vaccine Efficacy in Humans
Richard T. Wyatt,
IAVI Neutralizing Antibody Center, The Scripps Research Institute, USA
Analysis of HIV-1 Env and Elicited Antibody Responses for Improved Immunogen Design
Analysis of HIV-1 Env and Elicited Antibody Responses for Improved Immunogen Design
Nancy L. Haigwood,
Oregon Health & Science University, USA
Clues to Understanding the Role and Impact of Eliciting Neutralizing Antibodies
Clues to Understanding the Role and Impact of Eliciting Neutralizing Antibodies
08:00—11:15
Immune Tailoring in Non-Lymphoid Tissues
Meeting has ended...abstracts no longer viewable online.
Mark T. Heise,
University of North Carolina at Chapel Hill, USA
Systems Genetics and Regulation of Virus-Induced Inflammatory Responses
Systems Genetics and Regulation of Virus-Induced Inflammatory Responses
David L. Woodland,
Keystone Symposia on Molecular and Cellular Biology, USA
Lung Specific Recruitment of Virus-Specific T Cells during Acute Respiratory Infection
Lung Specific Recruitment of Virus-Specific T Cells during Acute Respiratory Infection
Yoshimasa Takahashi,
National Institute of Infectious Diseases, Japan
Short Talk: Memory B Cells in the Lung Participate in Protective Humoral Immune Responses to Pulmonary Influenza Virus Reinfection
Short Talk: Memory B Cells in the Lung Participate in Protective Humoral Immune Responses to Pulmonary Influenza Virus Reinfection
*
Cornelia C. Bergmann,
Cleveland Clinic Foundation, USA
Cell Type-Specific Immune Regulation during Viral Encephalomyelitis
Cell Type-Specific Immune Regulation during Viral Encephalomyelitis
Jasmin Herz,
University of Virginia, USA
Short Talk: Dynamics of Memory T Cells Clearing a Persistent Infection in the Absence of Severe Tissue Injury
Short Talk: Dynamics of Memory T Cells Clearing a Persistent Infection in the Absence of Severe Tissue Injury
Robert L. Hendricks,
University of Pittsburgh, USA
Manipulating HSV-Specific CD8+ T Cell Function to Control Latent Infections in Sensory Gangli
Manipulating HSV-Specific CD8+ T Cell Function to Control Latent Infections in Sensory Gangli
17:00—19:00
New Concepts Guiding Vaccine Development (Joint)
Meeting has ended...abstracts no longer viewable online.
Shane Crotty,
La Jolla Institute for Allergy and Immunology, USA
Designing Vaccines: Follicular Helper CD4 T Cells and their Roles in Generating Neutralizing Antibody Responses
Designing Vaccines: Follicular Helper CD4 T Cells and their Roles in Generating Neutralizing Antibody Responses
Robert A. Seder,
NIAID, National Institutes of Health, USA
Impact of Adjuvants on HIV-Specific Immune Responses
Impact of Adjuvants on HIV-Specific Immune Responses
Michel C. Nussenzweig,
HHMI/Rockefeller University, USA
Human Antibodies to HIV
Human Antibodies to HIV
*Session Chair †Invited, not yet responded.
Keystone Symposia thanks our Sponsors for generously supporting this meeting:
|
|
We gratefully acknowledge the generous grant for this conference provided by:
We gratefully acknowledge additional support for this conference from:
|
|
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
|
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: Sarah Lavicka,
Director of Development, Email: sarahl@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org, Phone:+1 970-262-2676 |
